Nexavar and Faecaloma - a phase IV clinical study of FDA data

Summary:

Faecaloma is reported as a side effect among people who take Nexavar (sorafenib tosylate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Deltasone, and have Hepatic neoplasm malignant.

The phase IV clinical study analyzes which people have Faecaloma when taking Nexavar. It is created by eHealthMe based on reports of 23,142 people who have side effects when taking Nexavar from the FDA, and is updated regularly.

What is Nexavar?

Nexavar has active ingredients of sorafenib tosylate. It is often used in hepatocellular carcinoma. eHealthMe is studying from 23,250 Nexavar users. Check the latest studies of Nexavar.

What is Faecaloma?

Faecaloma (hard mass of fecal matter) is found to be associated with 643 drugs and 1,079 conditions by eHealthMe. Check the latest studies of Faecaloma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

23,142 people reported to have side effects when taking Nexavar.
Among them, 16 people (0.07%) have Faecaloma.

Among these 16 people:

How long have people been on Nexavar when they have Faecaloma? *

What is the gender of people who have Faecaloma when taking Nexavar? *

female: 56.25 %
male: 43.75 %

What is the age of people who have Faecaloma when taking Nexavar? *

What are other drugs people take besides Nexavar? *

What are other side effects people have besides Faecaloma? *

Diarrhea: 10 people, 62.50%
Constipation: 7 people, 43.75%
Nausea (feeling of having an urge to vomit): 6 people, 37.50%
Skin Exfoliation (removal of the oldest dead skin cells): 6 people, 37.50%
Hair Loss: 6 people, 37.50%
Oral Pain: 6 people, 37.50%
Nausea And Vomiting: 6 people, 37.50%
Fatigue (feeling of tiredness): 4 people, 25.00%
Haematochezia (passage of stools containing blood): 4 people, 25.00%
Eye Haemorrhage (bleeding in the eye): 3 people, 18.75%

What are the existing conditions these people have? *

Pulmonary Oedema (fluid accumulation in the lungs): 2 people, 12.50%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 12.50%
Hepatic Neoplasm Malignant (liver cancer): 2 people, 12.50%
Prostate Cancer: 1 person, 6.25%
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Nexavar and have Faecaloma?

- Check whether Faecaloma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nexavar:

Nexavar (23,250 reports)

Faecaloma treatments and more:

Faecaloma (6,197 reports)

Browse all side effects of Nexavar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Faecaloma:

Faecaloma (643 drugs)

Browse all the conditions that are associated with Faecaloma:

Faecaloma (1,079 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sorafenib tosylate (the active ingredients of Nexavar) and Nexavar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.